Results 251 to 260 of about 119,519 (336)

The different faces of Janus kinase inhibition

Haematologica, 2012
Peter Vandenberghe
doaj   +1 more source

Adverse effects of Janus kinase inhibitors with relevance for daily practice in dermatology. [PDF]

J Dtsch Dermatol Ges
Rajput Khokhar A, Ghoreschi K, Huynh J.
europepmc   +1 more source

Inhibition of autophagy attenuated curcumol‑induced apoptosis in MG‑63 human osteosarcoma cells via Janus kinase signaling pathway

, 2017
Chuan Zhang, Limin Wang
openalex   +2 more sources

Safety and effectiveness of the combination of 5‐azacitidine and ruxolitinib in VEXAS syndrome: A single‐centre experience

British Journal of Haematology, EarlyView.
Gregorio Maria Bergonzi, Enrico Cozzo, Alessandro Tomelleri, Costanza Piccolo, Gianluca Scorpio, Carmelo Gurnari, Francesca Romano, Marco Matucci‐Cerinic, Lorenzo Dagna, Massimo Bernardi, Luca Vago, Fabio Ciceri, Corrado Campochiaro, Elisa Diral   +13 more
wiley   +1 more source

Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO‐2b/3

International Journal of Dermatology, EarlyView.
ABSTRACT Background Patients with alopecia areata (AA) in ALLEGRO‐2b/3 (NCT03732807) had clinically significant hair regrowth and patient‐reported improvements with ritlecitinib versus placebo, but patient‐reported improvements in AA Patient Priority Outcomes (AAPPO) emotional symptoms (ES) or activity limitations (AL) were not observed during the 24 ...
Ernest H. Law, Bintu Sherif, Arash Mostaghimi, Brett King, Rodney Sinclair, Natasha Mesinkovska, Kent A. Hanson, Dane Korver, Costel Chirila   +8 more
wiley   +1 more source

Janus kinase inhibitors - a role for the treatment of cutaneous T-cell lymphomas? [PDF]

Oncol Rev
Packer SE, Brunner PM.
europepmc   +1 more source

Efficacy of Janus kinase inhibitor combined with phototherapy in non-segmental vitiligo: systematic review and meta-analysis. [PDF]

Ann Med
Shuaib L, D Rai K, K Sangtiani A, Ishtiaq J, Mubeen M, Saeed A, Poudel S.   +6 more
europepmc   +1 more source

Differential response to Janus kinase inhibitors in refractory livedoid vasculopathy: Biomarker-guided therapy may improve clinical response. [PDF]

JAAD Int
Yu G, Zhu J, Zhang Y, Yang F, Yang J, Tao J.   +5 more
europepmc   +1 more source

LB1098 Association of sebaceous carcinoma and Janus kinase inhibitors: Case study and retrospective FAERS analysis [PDF]

Anupa Patel, L. Herbig, Paras P. Vakharia   +2 more
openalex   +1 more source